Top Markets
Coin of the day
Agile Therapeutics, Inc. Agile Therapeutics, Inc.

Agile Therapeutics, Inc.

AGRX
Rankning i aktier #38231
Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated... Agile Therapeutics, Inc. operates as a women's healthcare enterprise dedicated to the research, development, and market introduction of prescription contraception in the United States. Its flagship product is Twirla (also known by its development code, AG200-15), a combined hormonal contraceptive delivered through a patch applied once weekly. The company is also progressing with several pipeline innovations, including variations of Twirla and other new products: AG200-15 Extended Regimen (ER): A regimen designed to limit a woman to four withdrawal bleeding occurrences annually. AG200-15 smaller patch (SmP): This iteration aims for shorter, lighter withdrawal bleeds and potentially enhanced contraceptive efficacy. AG200-15 ER SmP: A combined regimen that allows for an extended contraceptive cycle while simultaneously providing fewer, lighter annual bleeding episodes. P-Patch: A contraceptive patch containing only progestin, specifically intended for women who cannot or choose not to use estrogen. Agile Therapeutics, Inc. was founded in 1997 and is based in Princeton, New Jersey.
Aktiekurs
$1.51
Senast synkroniserad: 2024-08-26
Marknadsvärde
$1.12M
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Agile Therapeutics, Inc. (AGRX)

Kategori

EPS för Agile Therapeutics, Inc. (AGRX)
EPS per June 2024 TTM: $-3.23
Enligt Agile Therapeutics, Inc.s senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $-3.23. Vid slutet av 2022 hade bolaget ett EPS på $-58.79, en minskning jämfört med EPS från 2021 som var $-63.12K.
EPS-historik för Agile Therapeutics, Inc. från 2012 till 2026
EPS vid slutet av varje år
År EPS Ändra
2026 (TTM) $-3.23 -51.86%
2023 $-6.71 -88.59%
2022 $-58.79 -99.91%
2021 $-63.12K 4,786.76%
2020 $-1.29K 73.08%
2019 $-746.20 -35.27%
2018 $-1.15K -36.99%
2017 $-1.83K -10.01%
2016 $-2.03K -26.22%
2015 $-2.76K -2.35%
2014 $-2.82K -11.05%
2013 $-3.17K -38.43%
2012 $-5.15K 0.00%
EPS för liknande företag eller konkurrenter